What are common supplements taken for Mast Cell Activation Syndrome (MCAS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Supplements for Mast Cell Activation Syndrome (MCAS)

The most effective supplements for managing MCAS include H1 antihistamines, H2 antihistamines, and mast cell stabilizers like cromolyn sodium, which should be used as the foundation of MCAS management before considering other supplements. 1

First-Line Supplements and Medications

Antihistamines

  • H1 Antihistamines:

    • Non-sedating options (preferred): Fexofenadine, cetirizine
    • Can be increased to 2-4 times standard dose for better symptom control
    • Target symptoms: flushing, pruritus, urticaria, tachycardia, dermatologic manifestations 1

  • H2 Antihistamines:

    • Options: Famotidine, ranitidine, cimetidine
    • Should be used concurrently with H1 antihistamines for enhanced effect
    • Target symptoms: abdominal discomfort, gastrointestinal symptoms, cardiovascular symptoms 1

Mast Cell Stabilizers

  • Cromolyn Sodium:
    • Dosing: Start low and gradually increase to 200mg 4 times daily (before meals and at bedtime)
    • Particularly effective for gastrointestinal symptoms (diarrhea, abdominal pain, nausea)
    • May also benefit neuropsychiatric manifestations 1
    • Available as oral solution, nasal spray, or topical formulation 2

Second-Line Supplements and Medications

Anti-inflammatory Options

  • Aspirin:

    • Consider for patients with flushing and hypotension, especially those with increased urinary prostaglandin levels
    • Dosing: May require up to 650mg twice daily
    • CAUTION: Contraindicated in patients with allergic reactions to NSAIDs
    • CAUTION: May trigger mast cell activation in some patients 2, 1

  • Leukotriene Receptor Antagonists (e.g., montelukast):

    • Useful for management of skin and gastrointestinal symptoms refractory to other treatments 2

Biologic Therapies

  • Omalizumab:
    • Consider for antihistamine-resistant symptoms
    • Particularly effective for recurrent anaphylaxis and skin symptoms
    • Less effective for gastrointestinal, musculoskeletal, and neuropsychiatric symptoms 2, 1

Natural Supplements with Evidence for Mast Cell Stabilization

Several flavonoids and plant compounds have shown mast cell stabilizing properties in research studies:

  • Quercetin:

    • Natural flavonoid with mast cell stabilizing properties
    • Has shown improvement in allergic rhinitis symptoms in clinical trials 3

  • Vitamin D:

    • May help reduce mast cell activation
    • Has shown improvement in allergic symptoms in randomized controlled trials 3

  • Resveratrol:

    • Demonstrated effectiveness in suppressing mast cell mediator release
    • Has shown improvement in allergic rhinitis symptoms in clinical trials 3

  • Curcumin:

    • Shows anti-inflammatory effects on mast cells
    • Has shown improvement in allergic symptoms in clinical trials 3

Emergency Management Supplements

  • Epinephrine Auto-injectors:
    • All MCAS patients should carry two epinephrine auto-injectors
    • Essential for those with history of systemic anaphylaxis or airway angioedema 1

Practical Considerations

Timing and Administration

  • Adjust timing of medications to ensure highest drug levels when symptoms are anticipated
  • For nighttime symptoms, consider adding a sedating antihistamine (e.g., hydroxyzine 10-25mg) to a non-sedating daytime regimen 1

Cautions with Supplements

  • Many dietary supplements contain multiple ingredients with undisclosed source/purity
  • Some may have biological effects or interact with other supplements or medications
  • When using natural supplements, look for products that disclose complete list of active ingredients, their source, purity, and exact concentration 4

Special Populations

  • For patients with moderate renal impairment, reduce cetirizine dose by half
  • For severe renal impairment, avoid cetirizine and levocetirizine
  • Use caution with antihistamines metabolized by the liver in patients with hepatic impairment 1

Monitoring and Follow-up

  • Regular assessment of symptom control and medication efficacy is crucial
  • Periodic laboratory evaluation during symptomatic episodes helps guide treatment adjustments
  • A multidisciplinary approach involving allergists, immunologists, and other specialists is essential for comprehensive management 1

References

1
Guideline

Management of Mast Cell Activation Syndrome (MCAS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

4
Research

Mast cells and mast cell mediators as targets of dietary supplements.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2004

Related Questions

What foods should be eliminated to manage mast cell activation syndrome?
Does Fodzyme help reduce food reactions in individuals with Systemic Mast Cell Activation Syndrome (SMAS)?
Can a patient with nocturnal diarrhea, acid reflux, nasal regurgitation, intermittent rash, orthostatic dizziness, lower leg swelling with pitting edema, and night sweats, whose symptoms worsen with diarrhea flares, meet the criteria for Mast Cell Activation Syndrome (MCAS)?
Is ashwagandha (Withania somnifera) appropriate for treating mast‑cell activation syndrome (MCAS)?
Can Mast Cell Activation Syndrome (MCAS) present with mild nausea, upset stomach, and a general feeling of being unwell between flares?
What was the rationale for the study by Widmer and colleagues comparing alcohol-based solutions containing povidone iodine (Polyvinylpyrrolidone-Iodine) or chlorhexidine gluconate (Chlorhexidine Gluconate) as preoperative antisepsis for cardiac or abdominal surgery?
What is the most appropriate oral antibiotic regimen for a patient with a purulent skin abscess due to methicillin-susceptible Staphylococcus aureus (MSSA) at the time of discharge?
When is therapeutic drug monitoring (TDM) appropriate for a patient switched to isavuconazole (isavuconazonium sulfate) due to acute kidney injury (Impaired renal function) while being treated for invasive pulmonary mucormycosis?
Does a daily dose of valacyclovir (Valtrex) reduce the risk of transmitting herpes to partners?
What is the recommended metformin dosage for a patient with moderate kidney impairment?
What are the guidelines for holding apixaban (eliquis) in a patient with epistaxis and a known pulmonary embolism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question